EIF4E and neoplasm: Indeed, several of those translation initiation inhibitors, including eIF4E antisense-oligonucleotides and silvestrol that inhibits the RNA helicase eIF4A, have recently produced encouraging anti-tumor effects with limited toxicity profiles in mouse; and some of these inhibitors have been tested in clinical studies [45-48].